期刊文献+

血清CysC与尿微量蛋白在肾脏疾病诊断中的意义 被引量:1

下载PDF
导出
摘要 目的研究血清半胱氨酸蛋白酶抑制蛋白C(CysC)与尿微量蛋白在肾脏疾病诊断中的意义。方法检测分析103例肾脏疾病病人,按肾小球滤过率(GFR)将其分为肾功能重度受损组、中度受损组、轻度受损组和肾功能正常对照组,测定血清CysC、BUN、Cr和尿微量蛋白α1—MG、ALB、IgG、RBP,各组指标进行统计分析及相关性研究。结果与对照组相比,重、中度受损组各项指标均明显升高,差异有显著性;而轻度受损组仅血清CysC和尿ALB的差异有显著性(P<0.01和P<0.05)。血清CysC与GFR有较高相关性(r=-0.744,P<0.01)。在肾脏轻度受损时,尿微量蛋白的异常早于血清CysC。结论检测病人尿微量蛋白可诊断早期肾脏疾病,检测血清CysC以了解肾功能受损的程度。
出处 《世界感染杂志》 2005年第3期216-218,共3页 World Journal of Infection
  • 相关文献

参考文献9

  • 1Flier G, Prien F, Volmer I, et al. Diagnostic sensitivity of serum cystatin C for impaired glomerular filteration rate [J]. Pediatr Nephrol 1999, 13(6): 501-505.
  • 2Piowowar A, Knapik KM, Buczynska H, et al. Plasma cystatin C concentration in non-insulin dependent diabetes mellitus: relation with nephropathy [J]. Aher Exp Warsz 1999, 47(5): 327-331.
  • 3施岚,吴亚君,崔世雄.Cystatin C、Cr及β_(2-m)比较分析肾功能损害[J].放射免疫学杂志,2002,15(5):306-307. 被引量:3
  • 4Tain S, Kusano E, Ohara T, et al. Cysctain C measurement and its practical use in patients with varion renal disease [J]. Clin Nephrol 1997, 48(1): 104-108.
  • 5李玉林,徐国宾,朱立华.Cystatin C与肌酐在评价肾小球滤过功能中的比较研究[J].中国实验诊断学,2001,5(4):154-156. 被引量:99
  • 6Le Bricon T, Thervet E, Froissart M, et al. Plasma cystatin C: a better marker of glomerular filtration rate then creatinine in kidney transplantation [J]. Clinical Biol Chem, 2000, 33(1): 232.
  • 7Randers E, Erlandsen EJ. Serum systatain C as an endogenous marker of the renal function [J]. Clin Chem Lab Me.d, 1999, 37(4):389.
  • 8Randers E, Erlandsen EJ, Pedersen OL, et al. Serum systatain C as an endogenous marker of the renal function in patients with normal to moderately impaired kidney function [J]. Clin Nephrol, 2000,54(3): 203.
  • 9Oddoze, -C; Morange, -S; Portugal, -H, et al. Cystatin C is not more sensitive than creatinine for detecting early renal damage in patientswith diabetes [J]. Am-J-Kidney-Dis, 2001, 38(2): 310-316.

二级参考文献14

  • 1[1]Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (Cystatin C) amongst the cysteine proteinase inhibitors[J ]. Biochem Biophys Res Commun, 1984, 120:631.
  • 2[2]Sirmonsen O, Grubb A, Thysell H. The Blood serum concentration of cystatin C as a measure of glomerular filtration rate[J ]. Scand J Clin Lab Invest, 1985, 45:97.
  • 3[3]Tian S, Kusano E, Tabei K, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J ]. Clin Nephrol,1997, 48:104.
  • 4[4]David JN, Hansa T, Robert GD, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J]. Kidney International, 1995, 47:312.
  • 5[5]Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle enhanced immunonephelometry on the Behring nephelometer systems BNA,BNII[J ]. Clin Chem, 1997, 43:1016.
  • 6[6]Fanos V, Mussap M, Plebani M, et al. Cystatin C in paediatric nephrology. Present situation and prospects [J ]. Minerva-Pediatr,1999, 51:167.
  • 7[7]Jung K, Jung M. Cystatin C: a promising marker of glomerular filtration rate to replace creatinine[J]. Nephron, 1995, 70:370.
  • 8[8]Ylinen EA, Ala Houhala M, Harmoinen AP, et al. Cystatin C as a marker for glomemlar filtration rate in pediatric patients[J ]. Pediatr Nephrol, 1999, 13:506.
  • 9堀尾勝,福永惠,折田羲正.Ccrの2時間法と24時間法臨床意羲の達こと基準值の逵この理由[J].酶床檢查,1998,42(1):110.
  • 10Filer G, Priem F, Vollmer I, G ellermann J, Jung K. Diagnestic sensitivity of serum systatin for impaired glomerular filtration rate. Pediatr Nephrol 1999; 13(6) :501

共引文献100

同被引文献7

  • 1Scherberich E,Msbauer A,Meissner A,et al.Kidney and serum derived protein into urine OF patients suffering from renal diseases or arterial hypertension[J].Klin Wochenschr,1989,67(17):44-47.
  • 2Reiber H.CSF Flow-Its Influence on CSF Concentration of Brain-Derived and Blood-Derived Proteins[M].New York:Plenum Press,2003:51-72.
  • 3Hofmann W,Edel HH,Walter G,et al.Harnuntersuchungen zur differenzierten Diagnostik einer Proteinurie[J].Dstrch Arztebl,2001,98(12):1401-1419.
  • 4Jürgen E.Scherberich,Differentielle klinische Bewertung der Proteinurieformen[J].Der Bayerische Internist,1998,18(11):80-88.
  • 5Reiber H.Cerebrospinal fliud analysis:disease-related data patterns and evaluation programs[J].J Neurol Sci,2001,184(3):101-122.
  • 6唐江涛,王兰兰,李立新,蔡蓓.Protis分析软件在评价神经系统疾病患者鞘内IgG合成与血脑屏障功能损伤中的应用[J].中华检验医学杂志,2009,32(1):55-60. 被引量:3
  • 7陈庆海,府伟灵.尿微量蛋白检测及临床应用的研究进展[J].国外医学(临床生物化学与检验学分册),2002,23(3):178-180. 被引量:91

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部